^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
CINtec® PLUS Cytology

Company:
Roche
Type:
FDA Approved
Related tests:

Details

Evidence
CINtec® PLUS Cytology is a triage test for cervical cancer screening, and the only test that uses dual-biomarker technology to simultaneously detect p16INK4a and Ki-67 proteins to provide a strong indicator of the presence of transforming HPV infections. CINtec® PLUS Cytology objectively resolves LSIL and ASC-US Pap cytology, allowing laboratory professionals to help physicians be certain they are only recommending follow-up for patients who can benefit the most. The test is used for women 25 – 65 years old who have tested positive for HPV. The test is also used for women 30 – 65 years old who tested negative with the Pap test and positive for the HPV.
Cancer:
Cervical Cancer
Method:
Immunohistochemistry (IHC)
Approvals
Date
Cancer
Gene
Drug
By
09/20/20
FDA